Study protocol: the ILANA study – exploring optimal implementation strategies for long-acting antiretroviral therapy to ensure equity in clinical care and policy for women, racially minoritised people and older people living with HIV in the UK – a qualitative multiphase longitudinal study design

INTRODUCTION: Cabotegravir and rilpivirine (CAB+RPV long-acting (LA)) is recommended as a treatment for HIV-1 allowing people living with HIV to receive 2 monthly injectable treatment, rather than daily pills. Providing injectable therapy in a system designed to provide and manage study participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Farooq, Hamzah Z, Apea, Vanessa, Kasadha, Bakita, Ullah, Sadna, Hilton-Smith, Gill, Haley, Amber, Scherzer, Jenny, Hand, James, Paparini, Sara, Phillips, Rachel, Orkin, Chloe M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335540/
https://www.ncbi.nlm.nih.gov/pubmed/37423623
http://dx.doi.org/10.1136/bmjopen-2022-070666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335540/
https://www.ncbi.nlm.nih.gov/pubmed/37423623
http://dx.doi.org/10.1136/bmjopen-2022-070666

Ejemplares similares